|
Nov 3
|
Gilead to Present Late Breaking Data and Real World Evidence Highlighting Key Hepatitis Indications at The Liver Meeting® 2023
|
|
Nov 2
|
Earnings Preview: Illumina (ILMN) Q3 Earnings Expected to Decline
|
|
Nov 2
|
Gilead and Kite Oncology Present Data Demonstrating Car T-cell Therapy Survival Benefit and Showcasing Latest Advances in Blood Cancer Portfolio at ASH 2023
|
|
Nov 1
|
Is Now The Time To Put Gilead Sciences (NASDAQ:GILD) On Your Watchlist?
|
|
Oct 31
|
Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?
|
|
Oct 31
|
Gilead's Commitment to Advancing Health Equity for Black Women and Ending the HIV Epidemic
|
|
Oct 31
|
Kite and Epic Bio Announce Collaboration to Develop New Therapies for Cancer
|
|
Sep 12
|
Time for Gilead Sciences-Heavy ETFs?
|
|
Sep 11
|
Gilead's (GILD) Trodelvy Combo Shows Promise in NSCLC Study
|
|
Sep 10
|
Gilead’s Phase 2 EVOKE-02 Study of Trodelvy® (sacituzumab govitecan-hziy) in Combination With KEYTRUDA® (pembrolizumab) Demonstrates Promising Clinical Activity in First-Line Metastatic Non-Small Cell Lung Cancer
|
|
Sep 9
|
Only Four Days Left To Cash In On Gilead Sciences' (NASDAQ:GILD) Dividend
|
|
Sep 8
|
The Unexpected Reason Gilead Just Notched Its Biggest Single-Day Move In A Month
|
|
Sep 8
|
US STOCKS-S&P 500 closes up slightly ahead of US inflation data
|
|
Sep 8
|
US STOCKS-Wall St rises as megacaps gain, yields slip ahead of US inflation data
|
|
Sep 8
|
US STOCKS-Wall St rises as megacaps gain, yields slip ahead of key inflation data
|
|
Sep 8
|
Unveiling Gilead Sciences (GILD)'s Value: Is It Really Priced Right? A Comprehensive Guide
|
|
Sep 8
|
Gilead Stock Looks Underappreciated and Oversold, Say BofA Analysts
|
|
Sep 8
|
Adobe upgraded, DigitalOcean double downgraded: Wall Street's top analyst calls
|
|
Sep 8
|
Gilead Prices $2 Billion of Senior Unsecured Notes
|
|
Sep 7
|
Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know
|